TRIXENGLU XR 10/5/1000MG TAB NEW

TRIXENGLU XR 10/5/1000MG is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 10mg, Linagliptin 5mg, and Metformin HCL 1000mg—three potent antidiabetic agents working synergistically to improve glycemic control. Empagliflozin helps reduce blood glucose by promoting urinary glucose excretion, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzymes. Metformin improves insulin sensitivity and reduces hepatic glucose production. This extended-release formulation ensures sustained therapeutic levels throughout the day. Ideal for patients requiring multi-drug therapy to achieve target blood sugar levels. Consult your healthcare provider to determine if TRIXENGLU XR is appropriate for your treatment plan.